Skinive, founded in 2020 and headquartered in The Netherlands, is revolutionizing the dermatology landscape with its AI-driven skin health diagnostic tools. The company's flagship product, the AI Skin Health Scanner, leverages advanced AI algorithms and the world's largest dermatological database to provide accurate assessments of skin pathologies.
With a CE-Mark and ISO13485 certification, the app not only fosters early detection of serious conditions like cancer but also empowers both medical professionals and regular users to monitor and maintain skin health with personalized recommendations. The product has already garnered a user base exceeding 1 million, achieving an impressive 4.6-star rating.
Operating at the intersection of AI, Digital Health, and Medical Devices, Skinive secured a €510K Early VC investment from Malta Enterprise in December 2022. As demand for accessible healthcare tools continues to rise, Skinive positions itself as a key player in the rapidly expanding digital health sector.